| Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis AJ Templeton, MG McNamara, B Šeruga, FE Vera-Badillo, P Aneja, ... Journal of the National Cancer Institute 106 (6), dju124, 2014 | 2967 | 2014 |
| Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer M Scaltriti, F Rojo, A Ocaña, J Anido, M Guzman, J Cortes, S Di Cosimo, ... Journal of the National Cancer Institute 99 (8), 628-638, 2007 | 1042 | 2007 |
| Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis AJ Templeton, O Ace, MG McNamara, M Al-Mubarak, FE Vera-Badillo, ... Cancer epidemiology, biomarkers & prevention 23 (7), 1204-1212, 2014 | 738 | 2014 |
| Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis E Amir, B Seruga, S Niraula, L Carlsson, A Ocaña Journal of the National Cancer Institute 103 (17), 1299-1309, 2011 | 678 | 2011 |
| High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene A Bruna, RS Darken, F Rojo, A Ocaña, S Peñuelas, A Arias, R Paris, ... Cancer cell 11 (2), 147-160, 2007 | 585 | 2007 |
| Neutrophils in cancer: prognostic role and therapeutic strategies A Ocana, C Nieto-Jiménez, A Pandiella, AJ Templeton Molecular cancer 16, 1-7, 2017 | 415 | 2017 |
| Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis FE Vera-Badillo, AJ Templeton, P de Gouveia, I Diaz-Padilla, PL Bedard, ... Journal of the National Cancer Institute 106 (1), djt319, 2014 | 394 | 2014 |
| Drug resistance in metastatic castration-resistant prostate cancer B Seruga, A Ocana, IF Tannock Nature reviews Clinical oncology 8 (1), 12-23, 2011 | 389 | 2011 |
| Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors JC Montero, S Seoane, A Ocaña, A Pandiella Clinical cancer research 17 (17), 5546-5552, 2011 | 317 | 2011 |
| Preclinical development of molecular-targeted agents for cancer A Ocana, A Pandiella, LL Siu, IF Tannock Nature reviews Clinical oncology 8 (4), 200-209, 2011 | 307 | 2011 |
| HER3 overexpression and survival in solid tumors: a meta-analysis A Ocana, F Vera-Badillo, B Seruga, A Templeton, A Pandiella, E Amir JNCI: Journal of the National Cancer Institute 105 (4), 266-273, 2013 | 240 | 2013 |
| Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis S Niraula, A Ocana, M Ennis, PJ Goodwin Breast cancer research and treatment 134, 769-781, 2012 | 222 | 2012 |
| Systemic therapy for non–clear cell renal cell carcinomas: a systematic review and meta-analysis FE Vera-Badillo, AJ Templeton, I Duran, A Ocana, P de Gouveia, P Aneja, ... European urology 67 (4), 740-749, 2015 | 208 | 2015 |
| The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs S Niraula, B Seruga, A Ocana, T Shao, R Goldstein, IF Tannock, E Amir Journal of Clinical Oncology 30 (24), 3012-3019, 2012 | 202 | 2012 |
| Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis A Ocana, F Vera-Badillo, M Al-Mubarak, AJ Templeton, ... PloS one 9 (4), e95219, 2014 | 178 | 2014 |
| Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer: a systematic review and meta-analysis H Goldvaser, TA Barnes, B Šeruga, DW Cescon, A Ocaña, D Ribnikar, ... JNCI: Journal of the National Cancer Institute 110 (1), 31-39, 2018 | 165 | 2018 |
| Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? M Yu, A Ocana, IF Tannock Cancer and Metastasis Reviews 32, 211-227, 2013 | 162 | 2013 |
| Resistance to antibody–drug conjugates S Garcia-Alonso, A Ocana, A Pandiella Cancer research 78 (9), 2159-2165, 2018 | 161 | 2018 |
| Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer FE Vera-Badillo, R Shapiro, A Ocana, E Amir, IF Tannock Annals of Oncology 24 (5), 1238-1244, 2013 | 153 | 2013 |
| Neuregulins and cancer JC Montero, R Rodríguez-Barrueco, A Ocaña, E Díaz-Rodríguez, ... Clinical cancer research 14 (11), 3237-3241, 2008 | 146 | 2008 |
